Kelly Downing

Statistics

Publications

Citations

323

H-Index

Active since

2012

Affiliations

Stanford University(Current)

Karolinska Institutet

Kelly Downing is an author at Stanford University specializing in atherosclerosis genetics, cardiovascular disease, and atherosclerosis molecular mechanisms.

Publications per year

2012–2015

Publications

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

Yoko Kojima, Kelly Downing, Ramendra Kundu et al. · Journal of Clinical Investigation · 2014 · 148 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +16

Loss of CDKN2B Promotes p53-Dependent Smooth Muscle Cell Apoptosis and Aneurysm Formation

Nicholas J. Leeper, Azad Raiesdana, Yoko Kojima et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 117 citations · Full text

Life Sciences, Genetics, Pathobiology +14

CDKN2B Regulates TGF β Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels

Vivek Nanda, Kelly Downing, Jianqin Ye et al. · Circulation Research · 2015 · 58 citations

Medicine, Genetics, Molecular Genetics +12

1–3 of 3